4//SEC Filing
NEWLINK GENETICS CORP 4
Accession 0001126234-17-000012
CIK 0001126234operating
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 6:29 PM ET
Size
13.3 KB
Accession
0001126234-17-000012
Insider Transaction Report
Form 4
NEWLINK GENETICS CORP(NLNK)
Link Charles J. Jr.
DirectorChairman of the Board & CEO
Transactions
- Award
Stock Option (Right to Buy)
2017-01-03+326,288→ 326,288 totalExercise: $10.55→ Common Stock (326,288 underlying) - Tax Payment
Common Stock
2017-01-03$10.28/sh−5,265$54,124→ 277,491 total - Tax Payment
Common Stock
2017-01-04$11.04/sh−3,169$34,986→ 274,322 total
Holdings
- 139(indirect: By Spouse)
Common Stock
- 25,000(indirect: By Spouse)
Common Stock
Footnotes (8)
- [F1]Represents shares of Common Stock withheld by the Issuer in satisfaction of its tax withholding obligation with respect to the vesting of 17,000 previously reported restricted stock units ("RSUs") granted to the Reporting Person.
- [F2]Includes 5,750 RSUs previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the "Plan"). The RSUs will vest, and shares will be delivered to the Reporting Person in one installment on January 2, 2018, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
- [F3]Includes 22,500 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on January 2, 2018, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
- [F4]Includes 34,980 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on January 4, 2018, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
- [F5]Represents shares of Common Stock withheld by the Issuer in satisfaction of its tax withholding obligation with respect to the vesting of 11,659 previously reported restricted stock units ("RSUs") granted to the Reporting Person.
- [F6]Grant to the Reporting Person of a stock option under the Plan on January 3, 2017 (the "Date of Grant"). 50% of the option vests and becomes exercisable in a series of 48 successive equal monthly installments beginning on February 3, 2017, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan. The option expires ten years after the Date of Grant.
- [F7]The remaining 50% of the stock options vest and become exercisable as follows: (i) 12.50% upon completion of current planned Phase 1 equivalency study of new Indoximod salt formulation with "completion" measured by the last patient enrolled in such study, (ii) 12.50% upon completion of the current planned Phase 1 study of pro-Indoximod new chemical entity with "completion" measured by the last patient enrolled in such study, (iii) 12.50% upon an increase of closing share price on Nasdaq Stock Market ("Nasdaq") by at least 33% above exercise price of the options when measured over 30 consecutive calendar days, provided such increase occurs within four years of Date of Grant, otherwise such options shall be cancelled, and (iv)12.50% upon an increase of closing share price on Nasdaq by at least 50% above exercise price of the options when measured over 30 consecutive calendar days, provided such increase occurs within four years of Date of Grant, otherwise such options shall be cancelled.
- [F8]Unless otherwise disclosed, the option expires ten years after the Date of Grant.
Documents
Issuer
NEWLINK GENETICS CORP
CIK 0001126234
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001126234
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 6:29 PM ET
- Size
- 13.3 KB